Inimur Myko (Ciclopirox Olamine)

Ciclopirox olamine disrupts the function of fungal cell membranes and chelates essential metal ions, which interferes with enzyme activity and nutrient transport. This dual action inhibits fungal growth and leads to cell death, helping to clear the infection.

The dosage of Inimur Myko is determined by the prescribing healthcare professional based on the severity of the infection and patient factors. Patients should follow the specific instructions provided by their clinician and the product label.

Safety data for ciclopirox olamine in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Inimur Myko.

To request Inimur Myko, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and necessary import documentation.

Inimur Myko, containing ciclopirox olamine, offers a broad spectrum of activity against yeast and dermatophyte fungi and works by a unique metal‑chelation mechanism. Compared with azole antifungals, it may have a lower risk of drug‑drug interactions and is effective for strains resistant to azoles.

Inimur Myko should be stored at temperatures below 25 °C, in its original packaging, and protected from moisture and direct sunlight. Keep the product out of reach of children and do not use it after the expiration date.

Inimur Myko is applied intravaginally as directed by a healthcare professional. The patient typically inserts the prescribed amount of the formulation into the vagina using the applicator provided, following the recommended frequency and duration of treatment.

Serious adverse reactions, although rare, can include severe allergic responses such as anaphylaxis, Stevens‑Johnson syndrome, or toxic epidermal necrolysis. Patients should seek immediate medical attention if they experience symptoms like extensive swelling, difficulty breathing, or widespread skin rash.

Individuals with a known hypersensitivity to ciclopirox olamine or any component of the formulation should avoid using Inimur Myko. Additionally, patients with severe, uncontrolled systemic infections or those using contraindicated vaginal products should consult a clinician before use.